Aroa Biosurgery
(ASX) ARX
Aroa Biosurgery Financials at a Glance
Market Cap
A$224.56M
Revenue (TTM)
A$133.18M
Net Income (TTM)
A$3.49M
EPS (TTM)
A$0.01
P/E Ratio
56.52
Dividend
A$0.00
Beta (Volatility)
0.06 (Low)
Dividend
A$0.00
Beta (Volatility)
0.06 (Low)
Price
A$0.65
Volume
180,699
Open
A$0.61
Price
A$0.65
Volume
180,699
Open
A$0.61
Previous Close
A$0.65
Daily Range
A$0.61 - A$0.66
52-Week Range
A$0.46 - A$0.80
Estimated Earnings Date
Nov 24, 2026
Dividend
A$0.00
Beta (Volatility)
0.06 (Low)
Price
A$0.65
Volume
180,699
Open
A$0.61
Previous Close
A$0.65
Daily Range
A$0.61 - A$0.66
52-Week Range
A$0.46 - A$0.80
Estimated Earnings Date
Nov 24, 2026
ARX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aroa Biosurgery
Industry
Biotechnology
Sector
Health CareCEO
Brian Roderick Ward, PhD, MBA
Website
www.aroa.comHeadquarters
Auckland, 2022, NZ
ARX Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
4%
Net Income Margin
3%
Return on Equity
5%
Return on Capital
7%
Return on Assets
3%
Earnings Yield
1.77%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
A$224.56M
Shares Outstanding
345.47M
Volume
180.70K
Avg. Volume
186.93K
Financials (TTM)
Gross Profit
A$79.63M
Operating Income
A$4.36M
EBITDA
A$9.03M
Operating Cash Flow
A$9.37M
Capital Expenditure
-A$985.46K
Free Cash Flow
A$8.39M
Cash & ST Invst.
A$22.60M
Total Debt
A$5.31M
Aroa Biosurgery Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$50.82M
+182.5%
Gross Profit
A$43.92M
+181.3%
Gross Margin
86.42%
N/A
Market Cap
A$224.56M
N/A
Market Cap/Employee
A$822.55K
N/A
Employees
273
N/A
Net Income
A$5.15M
+440.4%
EBITDA
A$8.12M
+645.1%
Quarterly Fundamentals
Total Cash
A$22.60M
+12.3%
Total Debt
A$5.31M
-16.0%
Accounts Receivable
A$33.84M
+40.7%
Inventory
A$5.01M
-40.6%
Long Term Debt
A$4.08M
-25.6%
Short Term Debt
A$1.23M
-26.7%
Return on Assets
3.47%
N/A
Return on Invested Capital
6.84%
N/A
Free Cash Flow
A$4.94M
+267.2%
Operating Cash Flow
A$5.44M
+343.3%